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Abstract
Background: Cataracts are the leading cause of blindness worldwide, accounting for 13-27% of
cases. Kohl-Chikni Dawa (KCD) is reputed for its beneficial effects in the treatment of premature
cataracts. However, its efficacy is yet to be tested. To investigate the rationality of the therapeutic
use of Kohl-Chikni Dawa (KCD) in Unani medicine.
Methods: The effect of Kohl-Chikni Dawa eye drops on naphthalene-induced cataracts in rats was
investigated by slit-lamp biomicroscopic analysis. The normal group of experimental animals was
administered with mineral oil (orally), while other groups were given naphthalene (orally) along
with local application of KCD eye drops (once and twice daily), placebo and distilled water (twice
daily). Initial morphological changes of the lenses were observed twice a week for two weeks, and
thereafter once a week for four weeks.
Results: Local application of KCD (twice daily) caused significant reduction in the lens opacification
after 2 to 4 weeks of naphthalene administration.
Conclusion: KCD eye drops may have the potential to delay progression of naphthalene-induced
cataracts in rats.
Background
In 1995, it was estimated that 38 million people in the
world i.e., 0.7% of the total population are blind, while an
additional 110 million people have visual impairment.
Cataracts are still a major cause of blindness, accounting
for 13–27% of the blind people, strongly increasing with
age [1]. Cataract formation is one of the irreversible proc-
esses for which modern medical science has no definite
cure except surgery. Drugs that may have prophylactic or
curative effects for cataract are lacking.
Ingestion of naphthalene can cause cataract in man [2] as
well as in experimental animals [3–5]. Uyama et al sug-
gested that naphthodiquinone, an oxidation product of
primary ingested naphthalene, is the cataractogenic sub-
stance [6]. The morphology of these cataracts has prompt-
ed some to suggest that experimental naphthalene
cataracts may be a good model for human age-related cat-
aracts [7].
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Kohl-Chikni Dawa (KCD) is a compound herbo-mineral
ophthalmic formulation (Kohl, Surma) of Indian origin
(invented by Hakeem Shareef Khan) used in Unani med-
icine [8]. The drug is reputed for its beneficial effects in the
treatment of premature cataract [9–14] with the fact that
no adverse effect or reaction is reported in the Unani liter-
ature about the drug. However, claim of its efficacy is yet
to be scientifically substantiated. The present study was
therefore undertaken to investigate the effects of KCD in
naphthalene-induced cataract in rats by adopting the
method of Guo-Tong Xu et al [15].
Methods
Drugs
The ratio (1:20:1) of the constituents used in KCD in-
cludes copper sulphate (S.D. Fine Chem. Ltd. Mumbai),
Hard soap (M. S. factory, Aligarh) and resin of Shorea ro-
busta (collected from market and authenticated at Depart-
ment of Chemistry, Faculty of Science, Hamdard
University, New Delhi). Naphthalene (CDH Pvt. Ltd.,
New Delhi), mineral oil (S. D. Fine Chem. Ltd, Mumbai)
and Tropicacyl plus (Tropicamide 0.8%, Phenylephrine
5%) (Sunways Pharmaceuticals Ltd.). Mustard oil smoke-
ash solution in distilled water (self-prepared) was used as
placebo drug.
Drug preparation
KCD was prepared after proper identification and quanti-
fication of the constituents under aseptic conditions as per
the method described [16,17]. Hard soap was cut into
small pieces and heated in an iron pot. As the soap started
to melt, copper sulphate was added and allowed a com-
plete liquefaction. Resin powder of Shorea robusta was
then added and heated till the drug got burnt and convert-
ed into dry ash. After cooling, the drug was powdered by
using a grinder and filtered through a sieve (size 120µ).
The filterate (micro-fine powder) was collected in a bottle
and labeled as Kohl-Chikni Dawa. Fresh solution (3%) (1
ml contain 45 mg) of KCD in distilled water was prepared
before instillation.
Animals
Fifty albino rats (female, 100–130 gm.) bred in the Cen-
tral Animal House Facility of Hamdard University were
used for the study. The animals were housed under stand-
ard laboratory conditions with food and water provided
ad libitum. Experiments were performed between 09:00
and 17:00 hrs. The animal ethics committee of Hamdard
University approved the study protocol.
Induction of cataract
Cataract induction was achieved by oral administration of
Naphthalene solution (10%), which was prepared in
warm mineral oil by heating at 60° C for 30 minutes. This
solution was administered orally by using 18-gauge nee-
dle at 0.5 gm/kg for 3 days and 1.0 gm/kg thereafter, for 4
weeks. One drop of 3 % KCD solution was applied locally
in both eyes daily, once a day and twice a day (at 9:00 and
17:00 hrs) just after the naphthalene administration. Typ-
ically, the experiment included 5 groups (oral: local): (I)
mineral oil: distilled water; (II) naphthalene: KCD (once
a day); (III) naphthalene: KCD (twice a day); (IV) naph-
thalene: mustered oil smoke-ash (twice a day) and (V)
naphthalene: distilled water (twice a day).
Determination of cataract opacification
Morphological changes in the lenses were monitored by
slit-lamp (Major Surgical Co.) after dilating the pupils by
Tropicacyl plus. The lenses were examined twice a week
during the first two weeks and thereafter at weekly inter-
vals for four weeks. The lenticular opacities were graded
with an arbitrary 6-score grading system as follows: 0,
clear lens; 1, watercleft and spoke-like opacities (<0.5 of
the shell); 2, watercleft and spoke-like opacities (>0.5 of
the shell); 3, opacities merged to form a shell (thin, grey
colour); 4, shell partly thick and white; and 5, shell fully
thick and white. Presence of opacification was confirmed
in all lenses after excising and examining them under a
dissecting microscope.
Statistical analysis
The slit-images of 6 eyes in each group were used for sta-
tistical analysis. Due to high mortality rate (about 30 % in
each naphthalene-fed groups), data of 6 animals were ex-
pressed as mean ± S.E.M. Non-paired student's t-test was
used to analyze significance of the two means. Probability
level of less than 5% was considered as statistically signif-
icant.
Results
All naphthalene-fed rats developed cataract with similar
morphological characteristics although the rate of devel-
opment varied with different groups. Under slit-lamp ex-
amination, waterclefts and spoke-like opacities in the
cortex could be seen after two weeks in groups II, IV and V
and by the fourth week these features merged to form a
partly thick and white shell in the deep cortex region and
did not produce fully thick and white shell in any group.
The opacities appeared creamish or light yellow on exam-
ining the lenses after their removal from eyeballs. The an-
imals of Gp. III treated with KCD (twice daily) developed
waterclefts and spoke-like opacities in the cortex at the
end of the third week and did not produce any thickening
and opacity of the shell. After removal from the eyeball
these opacities gave a ground-glass appearance.
Comparing the morphological development of cataracts
in the groups II, III, IV and V rats during four weeks of
naphthalene feedings, the Gp. IV and Gp. V rats showed a
similar rate of cataract formation. The rate of cataract de-BMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/13
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velopment was slightly faster in Gp. IV and Gp. V than in
Gp. II and Gp. III. The Gp. III rats developed cataract at a
slower pace than those of other groups, the difference be-
ing statistically significant (p < 0.05; p < 0.01). Gp. I rats
treated with mineral oil only remained clear during the
four week treatment (Figure 1). Some systemic disorders,
including diarrhoea, weight reduction, brownish colour
of hairs and high mortality (about 30%), were observed in
the naphthalene-fed animals. None of these extra-ocular
effects was prevented or ameliorated by KCD eye drops.
Discussion
In the long-term pharmacological treatment of cataract
safety considerations are of primary concern. To reduce
the side effects of long-term drug therapy and to achieve a
sufficient concentration of drug penetrating the lens, top-
ical administration is more effective than systemic admin-
istration [18]. Since the progression of age-related cataract
in humans is slow, the anti-cataract drug must be applied
for a longer duration, as we used KCD eye drops during
this study.
The study revealed that application of KCD  eye drops
twice a day significantly inhibited lens opacification in the
naphthalene-induced cataract. The mechanism of this in-
hibition remains unclear. Standardization of KCD, con-
taining 1.208% copper as one of the components, has
been discussed earlier [19]. We presume that cataract inhi-
bition by KCD could be mainly due to the presence of
copper in it; as Balaji et al [20] suggest that copper is nec-
essary for normal physiological function and is required
for the activity of numerous enzymes such as cytochrome
oxidase, super-oxide dismutase and uricase. The excess of
copper in cataractous lenses may oxidize sulfhydryl group
to disulfides followed by a reduction of copper that may
generate oxygen radicals.
The role of copper in cataractogenesis has been reported
variously. In one study, the copper level in the cataractous
lenses in vertebrates showed no correlation between cop-
per level and cataract, and found no difference in copper
levels between normal and cataractous lenses [21]. Low
level [22] as well as elevated level [23] of copper has been
observed in the cataractous lenses. The elevated level of
copper in the lens has been shown to inhibit the activity
Figure 1
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of lactate dehydrogenase, which is thought to be a sensi-
tive marker of cataract formation [24]. Thus, whatever be
the role of copper in cataractogenesis, it is suggested that
application of 3% KCD eye drops twice a day may prevent
naphthalene-induced cataract in rats. Moreover, KCD eye
drops may also prove to be a useful drug for age-related
human cataract.
Conclusion
Our findings suggest that local application of 3% KCD eye
drops has an anti-cataract effect in naphthalene-treated
rats. Thus, the reported claim about the efficacy of this
drug finds support from this study. That the drug has long
been in use of peoples is indicative of its being non-toxic.
However, drug penetration tests and controlled clinical
trials need to be carried out to confirm its anti-cataract ac-
tivity and general safety.
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